--Intent to award on a sole source basis for custom synthesis of botulinum toxin research reagents.

The US Army Medical Research Acquisition Activity plans to award a contract to the University of Massachusetts Dartmouth for the custom synthesis of botulinum toxin research reagents. This award will be made on a sole source basis to support the continuation of an ongoing research project. The decision to proceed without competition is based on the unique capability of the University of Massachusetts Dartmouth to meet the agency’s specific requirements, and the understanding that engaging other sources would cause significant delays, disrupt the progress of the current project, and increase costs to the Government. This acquisition follows the procedures outlined in FAR 6.302 for other than full and open competition. The notice specifies that no competitive quotes are being solicited at this time. However, any responses must be submitted in writing within fifteen days following the publication date and must provide clear and convincing evidence that an alternative source can meet the Government’s needs and that competition would benefit the Government. If no such responses are received, the contract will be awarded to the University of Massachusetts Dartmouth without further notice. The contract is related to the custom synthesis of botulinum toxin reagents and falls under the NAICS code 611310. For inquiries or responses, contact information is provided through the designated government point of contact.